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1. Introduction 
Hema~utinins from animal, plant, fungal, bacter- 
ial and viral origins have been described [l-S] . Their 
specificity is manifested in the spectrum of animal 
cells which they agglutinate and in their inhibition by 
certain carbohy~ates [ 1,2]. This specificity provides 
a unique opportunity for the investigation of the bio- 
chemical nature of the combining sites on cell mem- 
branes and other biological materials. The blood group 
specific hemag~utinins are inhibited by the sugars that 
determine the blood groups antigens [ 1,2,6,7] and 
the broad spectrum hemagglutinins are inhibited by 
different sugars. The phytohemag~utinin of P~~~eo~us 
vulgaris is inhibited by N-acetyl-D-galactosamine [ 1, 
2,8] ; the wheatgerm hemagglutinin s inhibited by 
terminal non-reducing N-acetyl-D-glucosamine [9]; 
concanavalin A of C~~~~~a e~sif~~is is inhibited by 
a-methyl-D-glucopyranoside [lo] and by various o- 
glucans [11, 121; the soybeans hemagglutinins are in- 
hibited by N-acetyl-D-galactosamine a dby D-galac- 
tose [13-l 61; the phytohema~uti~n of Pisum sati- 
vum is inhibited by D-mannose, D-glucose and D-fruc- 
tose [ 171 and the hemag@tination due to fava beans 
is inhibited by D-glucose, D-fructose and maltose [181. 
In the present study, bacterial hemagglutinin (BHA), 
separated from Pseudomonas aeruginosa cells, was 
found to exhibit a broad spectrum cell specificity, to 
a~utinate preferenti~ly papain or neuraminida~- 
treated erythrocytes and to be eluted from the cells 
by heating at 56-70’ or by acidification. The hemag 
glutination induced by the BHA was inhibited by D- 
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galactose, N-acetyl-D-galactosamine a dlactose. 
2. Materials and methods 
A pyocya~-producing strain of P. aeruginosa was 
grown in nutrient broth (Difco) with shaking at 28’ 
for 3 days. The growth medium was provided daily 
with 0.2% acetylcholine instead of glucose. The cells 
were harvested, washed 3times in an isotonic saline 
and suspended to obtain a 20% suspension. The cell 
suspension was exposed to Raytheon 10 KC 250W 
sonic oscillation for 5 min and centrifugated at 
30,000 g for 15 min. The supematant fluid, con- 
taining the bacterial hemagglutinins, was kept at 
-20”. 
Human and animal bloods were taken into one 
fifth of their volume of 3.8% sodium citrate solution, 
the erythrocytes were separated and washed 3 times 
in saline. Papain-treated rythrocytes [ 191 were pre- 
pared by incubation of 9 vol of 5% suspen~on of
washed erythrocytes with 1 vol of 1% papain (crude 
preparation, Sigma) in 0.1% cysteine solution at 37” 
for 30 min. Neuraminidase-treated erythrocytes were 
prepared by ~cubation of 9 vol of the 5% erythro- 
cyte suspension with 1 vol of neuraminidase olution 
(Serva preparation, which removes 500 pg of N-acetyl 
neuraminic acid in 15 min at 37”) in 0.05 M acetate 
buffer at pH 5.5 containing 0.01 M CaCl? . The en- 
zyme-treated cells were washed 3 times in saline. 
Hemagglutination tests were performed by addi- 
tion of 0.05 ml of 5% erythrocyte suspension (enzyme 
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Table 1 
Hemagglutination of untreated and enzyme-treated human and animal erythrocytes 
by the BHA preparation. 
Erythrocytes The BHA hemagglutination titer 
untreated: 
1 2 3 4 5 6 7 8 9 10 11 12 
Human ++++ ++ + _ 
Rat ++++ i+++ +++ + _ _ - - - 
Rabbit f _ _ _ _- - 
Dog +k++ ++++ +++ ++ - - . . - 
Mouse ++ + _ - - - - 
Sheep + _ _ - - - _ 
Neuraminidase 
treated: 
Human ++++ +*+ +-H+ +-H-i ++++ i-u u +I- f 
Papain 
treated: 
Human ++++ ++++ ff++ i+++ +++ -I++ ++ * +++ - - 
Rat ++++ ++++ ++++ ++t+ i+++ i-u+ +i++ +++ u-*+ - 
Rabbit *++ u++ +++ +++ ++ ti ++ i+ ++ + - - 
Dog +-I++ ++++ +-I++ -I+++ U-k+ ++++ ++++ ++++ +++ +++ ++ + 
Mouse tt++ ++++ ++++ i-u-i +++ +++ +++ + - - - - 
Sheep tt++ +I++ ++++ +i++ +++ ++ te +k f + - - 
The numbers represent a series of 2-fold dilutions of the BHA preparation beginning from l/40. The results presented are an aver- 
age of 2-10 tests. 
Table 2 
Hema~utination of papain-treats human erythrocytes by BHA prep~ations 
which were incubated with different sugars. 
The BHA hemag~utination titer 
1 2 3 4 5 6 7 8 9 10 11 
The sugar added 
to the BHA 
None ++k+ +*+ ++++ ++t+ ++++ ++++ ++++ ft+ i-k+ ++ + 
D-Glucose ++++ ++t+ ++++ +ft+ +++ ++ ++ ++ + + - 
D-Galactose _ - - 
D-Fructose ++++ ++++ ++++ ++++ +++ +t+ +++ +++ ++ + - 
D-Mannose ++++ ++++ ++++ ++k+ i-k+ +++ +++ ++ + - - 
N-Acetyl-D- 
glucosamine +*+ *++ ++++ ++++ ++-I-+ ++++ ++++ +i-k ++ +t - 
N-Acetyl-D- 
~acto~~ne ++ ++ ++ +-I- ++ + - - 
Lactose ++ ++ ++ + + f f t * f - 
The numbers represent a series of Zfold dilutions of the BHA preparation beginning from l/40. 
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treated or untreated cells) to serial 2-fold dilutions of 
the BHA preparation i  0.2 ml vol of saline, incuba- 
tion for 1 hr at room temp and a very short centrifu- 
gation. The degree of the agglutination was graded on 
a (-) to (+i++) scale. 
Rlution of the agglutinins from the cells was con- 
ducted by washing them 3 times and either suspend- 
ing them in saline and heating at S-70” for 10 min, 
or suspending them in saline containing 3.3% acetic 
acid with shaking for 10 min, cent~fugation and 
neutralization of the supernatant fluid, 
Inhibition of the agglutinating activity of the BHA 
by different sugars was examined by incubating 0.2 
ml of the BHA preparation, diluted l/20, with 0.2 
ml of a solution containing 10 mg of the examined 
sugar at room temp for 1 hr before titration of its 
hemagglutinating activity. 
3. Results and discussion 
The BHA from i? aeruginosa was separated from 
the bacterial cells by means of sonic vibrations and 
centrifugation. The subcellular preparation was found 
to resemble the broad-spectmm phytohemag~ut~ins 
in its activity. It agglutinated human red blood cells 
of different ABO, Rh and MN blood groups as did in- 
tact Pseudomonas bacteria [4] . The BHA agglutinated 
also the erythrocytes from various animals, including 
rats, rabbits, dogs, mice and sheep. The titer of ag- 
glutination of papain or neuraminidase treated cells 
was always much higher than that obtained for un- 
treated cells, resembling the behaviour of “incom- 
plete” antibodies and certain phytohemagglutinins 
[ 1, 2,8, 141 . These results are presented in table 1. 
Heating at 56” and acidification of the medium, 
which induce elution of antibodies and phytohemag- 
glutinins from a~utinin-coated cells, also eluted 
the bacterial hemagglutinins. Higher temperatures 
(up to 70’) could also be employed for elution of the 
relatively heat resistant BHA, which resemble phyto- 
hemagglutinins and not antibodies in this respect. 
The hema~utination by BHA was found to be 
strongly inhibited by Dgalactose, N-acetyl-D-galactos- 
amine and lactose. A very slight inhibition was observ- 
ed with some of the other sugars examined (table 2). 
N-Acetyl-Dgalactosamine also inhibits the hemagglut- 
inating activity of some broad spectrum phytohemag- 
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glutinins including those of P. vulgaris and soybeans 
[ 141. The BHA differ from Phaseolus hemagglutinins 
[ 1,2,8] in being strongly i~ibited by D-galactose. 
The biological significance of the reactions between 
bacterial hemag~utin~s and certain sugars and cell 
receptors, which are similar to those of certain phyto- 
hemagglutinins, is not understood. 
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